Source: Life Care News

Sage Therapeutics: SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE

NEW YORK & NEW ORLEANS-(BUSINESS WIRE)-Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Sage Therapeutics, Inc. ("Sage" or "the Company") (NasdaqGM: SAGE). Sage is a biopharmaceutical company that develops and commercializes brain [...]

Read full article »
Annual Revenue
$25-100M
Employees
250-500
Barry E. Greene's photo - CEO of Sage Therapeutics

CEO

Barry E. Greene

CEO Approval Rating

83/100

Read more